knowledge -WSS

knowledge

author：knowledge 2025-10-01 17:21:36 - browse：76

Blood corpuscles in clot — Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success. David Gregory & Debbie Marshall/Wellcome Images

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success.

LimFlow recently snagged Food and Drug Administration approval for its surgical system that uses a stent to connect a blocked artery to an open vein, thus allowing blood to flow through and heal injuries. The tool is meant only for patients with a severe form of peripheral artery disease, and who have already tried more conservative options.

Dan Rose, CEO of LimFlow, previously told STAT that his mission is to fight the amputation epidemic in the United States, which disproportionately impacts Black patients. Experts cautioned to STAT that expanding screenings to catch the disease early is still the most important measure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： People with mental disorders often marry others with same

WSS

Physicians aren't 'burning out.' They're suffering from moral injury

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Group behind ProMed defends move to subscription

Medicare Advantage 2025 payments will dip, Biden administration says

First Opinion on colorectal cancer screening: letter and response

Overprescribed: High cost isn't America's only drug problem

focus

knowledge

Wikipedia

Supreme Court strikes down use of affirmative action

A controversial new treatment promises to make little people taller

The high cost of giving birth even with insurance

Scientific mystery highlights the blind spots in genomics databases

Dobbs anniversary: the lost opportunity of abortion as health care

FDA scientists endorse Pfizer/BioNTech Covid

Affirmative action in medical school literally saved lives

A controversial new treatment promises to make little people taller

Tori Bowie and the unacceptable rates of Black maternal death

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

leisure time

Young boy dies in trial for Pfizer Duchenne gene therapy

Harvard scientists, with Google, unveil the most detailed brain map ever

Medicare Advantage 2025 payments will dip, Biden administration says

FDA scientists endorse Pfizer/BioNTech Covid

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Alzheimer's risk factor APOE4 may be a distinct form of the disease

explore

hotspot

explore

Wikipedia